AAAAAA

   
Results: 1-25 |
Results: 25
PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/
Authors: KHURI FR FOSSELLA FV LEE JS MURPHY WK SHIN DM MARKOWITZ AB GLISSON BS
Citation: Fr. Khuri et al., PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/, Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245
THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/
Authors: LEE JS PISTERS KMW KOMAKI R GLISSON BS PEREZSOLER R KHURI FR DELCLOS ME FOSSELLA FV
Citation: Js. Lee et al., THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/, Annals of oncology, 9, 1998, pp. 660-660
POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/
Authors: BRUNO R HILLE D RIVA A VIVIER N HUINNINK WWTB VANOOSTEROM AT KAYE SB VERWEIJ J FOSSELLA FV VALERO V RIGAS JR SEIDMAN AD CHEVALLIER B FUMOLEAU P BURRIS HA RAVCLIN PM SHEINER LB
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/, Journal of clinical oncology, 16(1), 1998, pp. 187-196
A PILOT TRIAL OF HYPERFRACTIONATED THORACIC RADIATION-THERAPY WITH CONCURRENT CISPLATIN AND ORAL ETOPOSIDE FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT
Authors: LEE JS KOMAKI R FOSSELLA FV GLISSON BS HONG WK COX JD
Citation: Js. Lee et al., A PILOT TRIAL OF HYPERFRACTIONATED THORACIC RADIATION-THERAPY WITH CONCURRENT CISPLATIN AND ORAL ETOPOSIDE FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT, International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 479-486
PHASE-II STUDY OF INTRAVENOUS ADENOSINE 5'-TRIPHOSPHATE IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER
Authors: HASKELL CM MENDOZA E PISTERS KMW FOSSELLA FV FIGLIN RA
Citation: Cm. Haskell et al., PHASE-II STUDY OF INTRAVENOUS ADENOSINE 5'-TRIPHOSPHATE IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER, Investigational new drugs, 16(1), 1998, pp. 81-85
GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT
Authors: ROTH JA SWISHER SG MERRITT JA LAWRENCE DD KEMP BL CARRASCO CH ELNAGGAR AK FOSSELLA FV GLISSON BS HONG WK KHURL FR KURIE JM NESBITT JC PISTERS K PUTNAM JB SCHRUMP DS SHIN DM WALSH GL
Citation: Ja. Roth et al., GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT, Seminars in oncology, 25(3), 1998, pp. 33-37
MAXIMUM-TOLERATED DOSE DEFINED FOR SINGLE-AGENT GEMCITABINE - A PHASE-I DOSE-ESCALATION STUDY IN CHEMOTHERAPY-NAIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LIPPMAN SM SHIN DM TARASSOFF P CALAYAGJUNG M PEREZSOLER R LEE JS MURPHY WK GLISSON B RIVERA E HONG WK
Citation: Fv. Fossella et al., MAXIMUM-TOLERATED DOSE DEFINED FOR SINGLE-AGENT GEMCITABINE - A PHASE-I DOSE-ESCALATION STUDY IN CHEMOTHERAPY-NAIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 310-316
RANDOMIZED STUDY OF CHEMOTHERAPY RADIATION-THERAPY COMBINATIONS FOR FAVORABLE PATIENTS WITH LOCALLY ADVANCED INOPERABLE NONSMALL CELL LUNG-CANCER - RADIATION-THERAPY-ONCOLOGY-GROUP(RTOG)-92-04
Authors: KOMAKI R SCOTT C ETTINGER D LEE JS FOSSELLA FV CURRAN W EVANS RF RUBIN P BYHARDT RW
Citation: R. Komaki et al., RANDOMIZED STUDY OF CHEMOTHERAPY RADIATION-THERAPY COMBINATIONS FOR FAVORABLE PATIENTS WITH LOCALLY ADVANCED INOPERABLE NONSMALL CELL LUNG-CANCER - RADIATION-THERAPY-ONCOLOGY-GROUP(RTOG)-92-04, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 149-155
PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/
Authors: LEE JS PISTERS KMW KOMAKI R GLISSON BS KHURI FR SCHEA R FOSSELLA FV
Citation: Js. Lee et al., PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/, Seminars in oncology, 24(4), 1997, pp. 52-55
MANAGEMENT STRATEGIES FOR RECURRENT NONSMALL CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS HONG WK
Citation: Fv. Fossella et al., MANAGEMENT STRATEGIES FOR RECURRENT NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 455-462
A PHASE-I INVESTIGATION OF THE SEQUENTIAL USE OF METHOTREXATE AND PACLITAXEL WITH AND WITHOUT G-CSF FOR THE TREATMENT OF SOLID TUMORS
Authors: HUBER MH LEE JS NEWMAN RA FOSSELLA FV WESTER M HONG WK LIPPMAN SM
Citation: Mh. Huber et al., A PHASE-I INVESTIGATION OF THE SEQUENTIAL USE OF METHOTREXATE AND PACLITAXEL WITH AND WITHOUT G-CSF FOR THE TREATMENT OF SOLID TUMORS, Annals of oncology, 7(1), 1996, pp. 59-63
CONCURRENT CHEMORADIATION THERAPY WITH ORAL ETOPOSIDE AND CISPLATIN FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - RADIATION-THERAPY ONCOLOGY GROUP PROTOCOL-91-06
Authors: LEE JS SCOTT C KOMAKI R FOSSELLA FV DUNDAS GS MCDONALD S BYHARDT RW CURRAN WJ
Citation: Js. Lee et al., CONCURRENT CHEMORADIATION THERAPY WITH ORAL ETOPOSIDE AND CISPLATIN FOR LOCALLY ADVANCED INOPERABLE NON-SMALL-CELL LUNG-CANCER - RADIATION-THERAPY ONCOLOGY GROUP PROTOCOL-91-06, Journal of clinical oncology, 14(4), 1996, pp. 1055-1064
PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
Authors: PEREZSOLER R FOSSELLA FV GLISSON BS LEE JS MURPHY WK SHIN DM KEMP BL LEE JJ KANE J ROBINSON RA LIPPMAN SM KURIE JM HUBER MH RABER MN HONG WK
Citation: R. Perezsoler et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, Journal of clinical oncology, 14(2), 1996, pp. 503-513
TREATMENT OF PATIENTS WITH SMALL-CELL LUNG CANCER REFRACTORY TO ETOPOSIDE AND CISPLATIN WITH THE TOPOISOMERASE-I POISON TOPOTECAN
Authors: PEREZSOLER R GLISSON BS LEE JS FOSSELLA FV MURPHY WK SHIN DM HONG WK
Citation: R. Perezsoler et al., TREATMENT OF PATIENTS WITH SMALL-CELL LUNG CANCER REFRACTORY TO ETOPOSIDE AND CISPLATIN WITH THE TOPOISOMERASE-I POISON TOPOTECAN, Journal of clinical oncology, 14(10), 1996, pp. 2785-2790
PHASE-I TRIAL OF GL331, A NOVEL TOPOISOMERASE-II (T-II) INHIBITOR FORADVANCED REFRACTORY CANCER
Authors: FOSSELLA FV NEWMAN R GORELICK K WESTER M KUNZ AY
Citation: Fv. Fossella et al., PHASE-I TRIAL OF GL331, A NOVEL TOPOISOMERASE-II (T-II) INHIBITOR FORADVANCED REFRACTORY CANCER, European journal of cancer, 31A, 1995, pp. 937-937
PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE LUNG PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
Authors: PEREZSOLER R FOSSELLA FV MURPHY WK GLISSON BS LEE JS HONG WK
Citation: R. Perezsoler et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE LUNG PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 1076-1076
PHASE-I EVALUATION OF ALL-TRANS-RETINOIC ACID WITH AND WITHOUT KETOCONAZOLE IN ADULTS WITH SOLID TUMORS
Authors: LEE JS NEWMAN RA LIPPMAN SM FOSSELLA FV CALAYAG M RABER MN KRAKOFF IH HONG WK
Citation: Js. Lee et al., PHASE-I EVALUATION OF ALL-TRANS-RETINOIC ACID WITH AND WITHOUT KETOCONAZOLE IN ADULTS WITH SOLID TUMORS, Journal of clinical oncology, 13(6), 1995, pp. 1501-1508
PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS SHIN DM CALAYAG M HUBER M PEREZSOLER R MURPHY WK LIPPMAN S BENNER S GLISSON B CHASEN M HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 645-651
INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER
Authors: KOMAKI R SHIN DM GLISSON BS FOSSELLA FV MURPHY WK GARDEN AS OSWALD MJ HONG WK ROTH JA PETERS LJ HOLOYE PV ELLERBROEK N
Citation: R. Komaki et al., INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 31(4), 1995, pp. 807-811
SUMMARY OF PHASE-II DATA OF DOCETAXEL (TAXOTERE), AN ACTIVE AGENT IN THE FIRST-LINE AND 2ND-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS BERILLE J HONG WK
Citation: Fv. Fossella et al., SUMMARY OF PHASE-II DATA OF DOCETAXEL (TAXOTERE), AN ACTIVE AGENT IN THE FIRST-LINE AND 2ND-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 22(2), 1995, pp. 22-29
PROSPECTIVE-STUDY OF COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN FOR UNRESECTABLE OR METASTATIC MALIGNANT PLEURAL MESOTHELIOMA
Authors: DONG MS FOSSELLA FV UMSAWASDI T MURPHY WK CHASEN MH WALSH G KOMAKI R MCMURTREY MJ HONG WK
Citation: Ms. Dong et al., PROSPECTIVE-STUDY OF COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN FOR UNRESECTABLE OR METASTATIC MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 76(11), 1995, pp. 2230-2236
PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS MURPHY WK LIPPMAN SM CALAYAG M PANG A CHASEN M SHIN DM GLISSON B BENNER S HUBER M PEREZSOLER R HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1238-1244
DOSIMETRY AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN DUE TO SKELETAL METASTASES
Authors: BAYOUTH JE MACEY DJ KASI LP FOSSELLA FV
Citation: Je. Bayouth et al., DOSIMETRY AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN DUE TO SKELETAL METASTASES, The Journal of nuclear medicine, 35(1), 1994, pp. 63-69
ANALYSIS OF URINE SAMPLES FROM METASTATIC BONE CANCER-PATIENTS ADMINISTERED SM-153 EDTMP
Authors: GOECKELER WF STONEBURNER LK KASI LP FOSSELLA FV PRICE DR FORDYCE WA
Citation: Wf. Goeckeler et al., ANALYSIS OF URINE SAMPLES FROM METASTATIC BONE CANCER-PATIENTS ADMINISTERED SM-153 EDTMP, Nuclear medicine and biology, 20(5), 1993, pp. 657-661
PHARMACOKINETICS AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN
Authors: BAYOUTH JE MACEY DJ KASI LP FOSSELLA FV
Citation: Je. Bayouth et al., PHARMACOKINETICS AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN, The Journal of nuclear medicine, 34(5), 1993, pp. 134-134
Risultati: 1-25 |